GSK945237: Clinical Trials

2 trials of GSK945237, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1

Follow GSK945237: new trials by email Literature Review of GSK945237 trials Research Report on GSK945237

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.
GSK945237, Placebo, Linezolid - Infections, Bacterial
Phase 1WithdrawnGlaxoSmithKline2009-11-012015-04-22
To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects
GSK945237, Sugar Pill - Healthy Subjects, Infections, Bacterial
Phase 1CompletedGlaxoSmithKline682007-07-012012-03-19

Conditions studied

Bacterial Infections (2)

Sponsors

GlaxoSmithKline (2)

Countries

Australia (1)